Cargando…
Serum Inflammatory Biomarkers Contribute to the Prognosis Prediction in High-Grade Glioma
BACKGROUND: To evaluate the prognostic value of serum inflammatory biomarkers and develop a risk stratification model for high-grade glioma (HGG) patients based on clinical, laboratory, radiological, and pathological factors. MATERIALS AND METHODS: A retrospective study of 199 patients with HGG was...
Autores principales: | Chen, Xiao-Yong, Pan, Ding-Long, Xu, Jia-Heng, Chen, Yue, Xu, Wei-Feng, Chen, Jin-Yuan, Wu, Zan-Yi, Lin, Yuan-Xiang, You, Hong-Hai, Ding, Chen-Yu, Kang, De-Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828473/ https://www.ncbi.nlm.nih.gov/pubmed/35155182 http://dx.doi.org/10.3389/fonc.2021.754920 |
Ejemplares similares
-
NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma
por: Ren, Wenjun, et al.
Publicado: (2022) -
Novel Biomarker Genes for Prognosis of Survival and Treatment of Glioma
por: Zhu, Xiaopeng, et al.
Publicado: (2021) -
The Ratio of Preoperative Serum Biomarkers Predicts Prognosis in Patients With Oral Squamous Cell Carcinoma
por: Ding, Meng, et al.
Publicado: (2021) -
Establishment and Validation of an Integrated Model to Predict Postoperative Recurrence in Patients With Atypical Meningioma
por: Chen, Xiao-Yong, et al.
Publicado: (2021) -
Based on clinical Ki-67 expression and serum infiltrating lymphocytes related nomogram for predicting the diagnosis of glioma-grading
por: Zhang, Zhi, et al.
Publicado: (2022)